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Abstract
Carrillo-Larco, Rodrigo M., J. Jaime Miranda, Robert H. Gilman, Offdan Narvaez-Guerra, Karela Herrera-
Enriquez, Josefina Medina-Lezama, Liam Smeeth, William Checkley, and Antonio Bernabe-Ortiz; on behalf of
the CRONICAS Cohort Study Group. Urbanization and altitude are associated with low kidney function in
Peru. High Alt Med Biol. 20:133–140, 2019.
Background: Kidney health needs to be studied in low- and middle-income countries with populations living at
high altitude and undergoing urbanization. We studied whether greater level of urbanization was associated
with worse kidney function and higher hemoglobin was associated with worse kidney function at high altitude.
Methods: Cross-sectional analysis of population-based studies in Peru including five sites at different altitude above
the sea level and urbanization level (in decreasing order of urbanization): Lima (sea level), Arequipa (2335 m),
urban Puno (3825 m), Tumbes (sea level), and rural Puno (3825 m). The exposures were urbanization and altitude
as per study site, and hemoglobin (g/dL). The outcome was the estimated glomerular filtration rate (eGFR).
Results: Four thousand two hundred eight people were studied: mean age was 57.4 years (standard deviation: 12.4)
and 51.9% were women. In comparison to rural Puno, eGFR was similar in Lima; in comparison to rural Puno,
Arequipa, urban Puno, and Tumbes had worse eGFR, for example, in Arequipa, b=-8.07 (95% confidence interval
[CI]: -10.90 to -5.24). Intermediate (b=-8.60; 95% CI: -10.55 to -6.66) and high (b=-11.21; 95% CI: -14.19 to
-8.24) altitude were negatively correlated with eGFR when only urban places were analyzed. At high altitude,
there was a trend for a negative association between hemoglobin and eGFR: b=-1.09 (95% CI: -2.22 to 0.04).
Conclusions: Apparently, higher altitude and level of urbanization, except for one highly urbanized site, were
associated with worse kidney function. Our findings suggest that some of the adverse impact of high altitude on
kidney function has been balanced by the lower risk conferred by rural environments.
Keywords: altitude; chronic kidney disease; glomerular filtration; kidney function; Peru; urbanization
Introduction
Despite the high global burden of chronic kidneydisease (GBD 2016 Risk Factors Collaborators, 2017a,
2017c), kidney health remains understudied in low- and
middle-income countries (LMICs), many of which host
populations living at high altitude (Cohen and Small, 1998;
worldatlas). In addition to risk factors for impaired kidney
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health associated with urbanization being experienced by
LMICs (e.g., diabetes or hypertension), high altitude also
imposes physiological challenges (e.g., chronic hypoxia) that
influence kidney function (Luks et al., 2008; Arestegui et al.,
2011). Therefore, studying kidney function across altitude
and urbanization levels could inform where kidney health
needs interventions to prevent diseases.
Erythropoiesis is associated with both kidney function and
high altitude. At high altitude, greater hemoglobin would be
expected; conversely, in the presence of kidney damage,
hemoglobin would be expected to fall. Because people with
impaired kidney function could response better to erythro-
poietin needing smaller doses to maintain high hematocrit, it
has been reported that, at high altitude, people with impaired
kidney function would have higher hemoglobin than people
with normal kidney function (Hurtado-Arestegui et al.,
2018). Further verification of this finding with a large
population-based sample at different altitudes above the sea
level could strengthen this observation and thus inform future
studies and interventions.
To study the association between urbanization as well as
high altitude and kidney function, and the association be-
tween hemoglobin and kidney function at high altitude, we
tested these hypotheses: (1) greater level of urbanization
would be associated with worse kidney function and (2)
higher hemoglobin would be associated with worse kidney
function at high altitude.
Materials and Methods
Study design and setting
This is a cross-sectional study using data of the PRE-
VENCION study (Medina-Lezama et al., 2005) and the
second follow-up round of the CRONICAS Cohort Study
(Miranda et al., 2012). These are population-based studies
conducted in 2004–2006 and 2013–2014, respectively. The
PREVENCION study was conducted in Arequipa at 2335 m
above the sea level. The CRONICAS Cohort Study was
conducted in Lima, Tumbes, rural Puno, and urban Puno;
Lima and Tumbes are at sea level, whereas both Puno sites
are at 3825 m above the sea level. These five study sites have
different degree of urbanization: Lima is highly urbanized
followed by Arequipa, urban Puno, Tumbes, and rural Puno
(Medina-Lezama et al., 2005; Miranda et al., 2012). To
classify the study sites according to the degree of urbaniza-
tion, the urbanicity scale adapted from Dahly and Adair
(2007) was used.
Population
People in the PREVENCION study were sampled fol-
lowing a probabilistic multistage approach. Stratification was
based on socioeconomic status (i.e., household sanitation and
access to basic services) and geographic location (i.e., the city
was divided into clusters of 50 blocks and these further di-
vided into aggregates of roughly 150 households each). The
sampling aimed to include more than 200 people in each age
group (15-year age groups from 20 years old up to age 80)
(Medina-Lezama et al., 2005). For this work, people in the
PREVENCION study were excluded if they had missing
creatinine test (n = 1). For comparison purposes with the
CRONICAS Cohort Study, people aged <35 years were ex-
cluded (n = 423). From the initial sample size of 2106, we
studied 1682 people.
Participants in the CRONICAS Cohort Study were ran-
domly selected following a sex- and age-stratified technique
(10-year age groups from age 35 and 65+ years). The sampling
frame was based on a census of each study site. Pregnant
women, people with pulmonary tuberculosis, and those with
disabilities that could have prevented fulfilling the clinical
evaluation were excluded (Miranda et al., 2012). The CRO-
NICAS Cohort Study included 3601 people at baseline, though
creatinine tests were only collected in the second follow-up
visit. We excluded people who had missing creatinine values
(n= 1067). Individuals with missing information to compute
the glomerular filtration rate (eGFR) were also excluded
(n= 5). This process left 2526 people for the analysis.
The total sample size included in the analysis was 4208
people: 905 in Lima, 1682 in Arequipa, 390 in urban Puno,
901 in Tumbes, and 330 in rural Puno.
Variables
Data collection of the CRONICAS Cohort Study and the
PREVENCION study has been detailed elsewhere (Medina-
Lezama et al., 2005; Miranda et al., 2012). In brief, data
collection was conducted with paper-based questionnaires
applied by trained fieldworkers, who also conducted the
clinical evaluation including weight, height, and blood pres-
sure (Chobanian et al., 2003). Blood samples for hemoglo-
bin, creatinine, and fasting glucose were taken by trained
technicians after an overnight fasting period (Medina-Lezama
et al., 2005; Miranda et al., 2012). All blood samples of the
PREVENCION study were analyzed by one laboratory, and
so were blood samples of the CRONICAS Cohort Study.
Hypertension was defined as measured raised blood pres-
sure (‡140/90 mmHg), self-reported diagnosis and currently
under treatment. Diabetes was defined as fasting plasma
glucose ‡126 mg/dL or self-reported diagnosis. Body mass
index (BMI) was calculated using measured weight and
height as kg/m2. Excessive erythrocytosis was defined as
hemoglobin ‡21 and ‡19 g/dL for men and women, respec-
tively (Leon-Velarde et al., 2005). Education level had four
categories: none, primary education, secondary education,
and higher education.
The outcome was eGFR as per the Modification of Diet in
Renal Disease (MDRD) equation [units: mL/(min $1.73 m2)]
(National Institute of Diabetes and Digestive and Kidney
Diseases); for descriptive purposes, eGFR was divided into
three categories: <60, 60–89, and ‡90. The three predictors of
interest were as follows: (1) study site and thus the degree of
urbanization (Lima > Arequipa > urban Puno > Tumbes >
rural Puno); (2) altitude above the sea level (low altitude
[Lima and Tumbes], intermediate altitude [Arequipa], and
high altitude [both Puno sites]); and (3) hemoglobin level in
g/dL, which was further dichotomized at 13 and 12 g/dL for
men and women, respectively (Organizacio´n Mundial de la
Salud).
Statistical analysis
Analysis was conducted with STATA 13.0 (StataCorp,
College Station, TX). Means, standard deviations (SDs), and
relative frequencies were estimated for descriptive purposes.
Comparisons between categorical variables were conducted
with the chi-square test. Comparison between numerical
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variables across levels of a categorical variable was per-
formed with the analysis of variance test; the Bonferroni test
was used to assess pairwise differences.
Linear regression models including robust standard errors
were fitted to address the associations of interest: (1) eGFR
and urbanization; (2) eGFR and altitude above the sea level;
(3) eGFR and altitude among urbanized sites only (i.e., ex-
cluding Tumbes and rural Puno) to verify if the effect of
altitude is similar across alike places; and (4) eGFR and he-
moglobin by altitude levels. All models were presented as
crude and adjusted. The first three models included these
covariates: sex, age (numeric), education, hypertension, di-
abetes, BMI (numeric), height (numeric), and hemoglobin;
the last model included these covariates except hemoglobin,
which was the exposure of interest.
Ethics
All participants gave an informed consent, and both studies
were approved by institutional review boards: Universidad
Peruana Cayetano Heredia (Lima, Peru) and Johns Hopkins
University (Baltimore, Maryland) approved the CRONICAS
Cohort Study; the Santa Maria Catholic University Human
Research Committee (Arequipa, Peru) approved the PRE-
VENCION study (Medina-Lezama et al., 2005; Miranda
et al., 2012).
Results
Study sample
The mean age was 57.4 years (SD: 12.4), ranging from 35
to 94 years; there were more women (51.9%). The study
population was homogenous regarding socio-demographic
characteristics except for education: rural Puno had more
people with no formal education (7.6%, p < 0.001). There
were fewer anemia cases at high altitude: 1.0% and 0.6% in
urban and rural Puno ( p < 0.001), respectively; these figures
for excessive erythrocytosis were 5.6% and 2.1% ( p < 0.001,
Supplementary Table S1).
eGFR variation according to study site and altitude
Figure 1 shows the mean eGFR according to study site and
altitude; Supplementary Table S2 shows eGFR box plots by
study site. Lima and rural Puno had similar eGFR (&102);
accordingly, these study sites also had similar creatinine
values (Supplementary Table S2). More than 20% of the
study population across sites had an eGFR between 60 and
89, and the largest proportion of individuals with an eGFR
‡90 was found in Lima and rural Puno (Fig. 2). There seemed
to be a negative association between eGFR and urbanization
(Table 1): for example, in comparison to rural Puno, people in
Arequipa would have in average -8.07 (95% confidence in-
terval [CI]: -10.90 to -5.24) eGFR units. According to the
results presented in Figure 1, there was not a strong difference
between rural Puno and Lima (Table 1).
Regarding altitude above the sea level, eGFR did not seem
to follow a positive linear relationship with the smallest
eGFR found at intermediate altitude (Fig. 1). A similar
proportion of subjects with an eGFR ‡90 was found at low
and high altitude (Fig. 2). The adjusted regression model
depicted lower eGFR at intermediate altitude (b = -3.93;
95% CI: -5.55 to -2.32) versus low altitude when all sites
were included; when this model was restricted to urban
places alone, that is, Tumbes and rural Puno were ex-
cluded, there was lower eGFR at intermediate (b = -8.60;
95% CI: -10.55 to -6.66) and high altitude (b = -11.21;
95% CI: -14.19 to -8.24, Table 1).
The association between hemoglobin and eGFR
Figure 3 signals that, regardless of the eGFR category,
people living at high altitude had higher hemoglobin than
people at sea level. Within each level of altitude, most
comparisons of mean hemoglobin across eGFR categories
were nonsignificant, suggesting that people with an eGFR
<60 had similar hemoglobin to a person with an eGFR ‡90
within each level of altitude.
The adjusted regression models suggest that there was a
negative weak association between hemoglobin and eGFR
levels at high altitude: for each additional hemoglobin unit,
the eGFR could have been expected to fall by -1.09 (95%
CI: -2.22 to 0.04) units (Table 2). To understand whether
this negative association existed regardless of the overall
hemoglobin level, we stratified the regression model at
high altitude by hemoglobin tertile (first tertile bottom).
These stratified models did not yield any strong associa-
tions in the first and second tertile, although in the top
tertile, the association was stronger than the one already
reported: -2.52 (95% CI: -3.63 to -1.41), suggesting that
at high altitude and among individuals with high hemo-
globin, the hemoglobin level is negatively associated with
the eGFR.
FIG. 1. Mean (SD) eGFR as per the MDRD equation according to site and altitude. p-Values correspond to the Bonferroni
multiple comparison test (analysis of variance). Pairwise relationships where no p-values are shown were p< 0.050. eGFR,
estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; SD, standard deviation.
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Discussion
Main findings
The take-home message of this work is that in five Per-
uvian sites at different level of urbanization and altitude
above the sea level there may be a negative association be-
tween greater urbanization and kidney function as per eGFR;
nevertheless, these estimates need to be understood in context
with the limitations of the study and with the fact that there
was not a strong difference between the most and least ur-
banized study sites. However, the results also suggest that
higher hemoglobin level is associated with worse eGFR in
high altitude sites and among people with high hemoglobin;
this finding needs to be interpreted accounting for the limi-
tations of the study such as lack of adjustment for some po-
tential confounders (e.g., diet). Overall, these results draw
attention to kidney health in places undergoing urbanization,
where most resources are being allocated to address other—
important—noncommunicable diseases. These findings call
to better understand the role of hemoglobin in kidney func-
tion at high altitude.
Results interpretation: eGFR and urbanization
The first hypothesis was that greater level of urbanization
would be associated with worse kidney function. Accounting
for the limitations of the study, our results partially supported
this hypothesis; although three urbanized places had lower
eGFR than the least urban study site, the study site with the
greatest level of urbanization had a similar eGFR as the least
urbanized setting.
Our findings partially suggest that higher urbanization is
associated with lower eGFR. This could be because of the
high frequency of unhealthy lifestyles (e.g., sedentarism) and
diseases (e.g., diabetes) in more urbanized places. Our results
support this assumption: hypertension, diabetes, and obesity
prevalence were the lowest in rural Puno. Obesity, diabetes,
hypertension, and high cholesterol are on the rise across the
world with larger burden in LMICs [NCD Risk Factor Col-
laboration (NCD-RisC), 2016, 2017a, 2017b]. Reducing
these risk factors should be a priority not only because of their
impact on cardiovascular health but also because of their
relation with kidney health (Global Burden of Metabolic Risk
Factors for Chronic Diseases Collaboration, 2014; GBD 2016
Risk Factors Collaborators, 2017b).
An unexpected finding of this work was the similar eGFR
between Lima (sea level and highly urbanized) and rural
FIG. 2. Proportion of people in each eGFR category ac-
cording to study site and altitude.
Table 1. Association Between Estimated Glomerular Filtration Rate [mL/(min$1.73m2)] and Study Site
As Well As Altitude Above the Sea Level
Crude Model A Model B
b (95% CI) b (95% CI) b (95% CI)
Study site (degree of urbanization) N = 4208 N= 4101 N = 4046
Rural Puno 1 1 1
Tumbes ({) -10.13 (-12.80 to -7.46) -7.12 (-9.92 to -4.32) -7.16 (-10.33 to -3.99)
Urban Puno ({{) -14.11 (-16.96 to -11.26) -10.83 (-13.91 to -7.74) -10.78 (-13.88 to -7.69)
Arequipa ({{{) -13.45 (-15.89 to -11.02) -8.22 (-10.92 to -5.53) -8.07 (-10.90 to -5.24)
Lima ({{{{) -0.42 (-3.06 to 2.22) 0.31 (-2.48 to 3.09) 0.31 (-2.89 to 3.51)
Altitude above the sea level N = 4208 N= 4101 N = 4046
Low altitude 1 1 1
Intermediate altitude -8.19 (-9.59 to -6.78) -4.26 (-5.70 to -2.81) -3.93 (-5.55 to -2.32)
High altitude -2.38 (-4.19 to -0.56) -2.53 (-3.34 to -0.71) -2.13 (-4.63 to 0.37)
Altitude above the sea level among
urban sites
N = 2977 N= 2894 N = 2839
Low altitude 1 1 1
Intermediate altitude -13.03 (-14.72 to -11.34) -8.66 (-10.43 to -6.88) -8.60 (-10.55 to -6.66)
High altitude -13.69 (-15.94 to -11.44) -11.08 (-13.33 to -8.82) -11.21 (-14.19 to -8.24)
Model A includes sex, age (numeric variable), education, hypertension, diabetes, BMI (numeric variable), and height (numeric variable),
whereas model B also includes hemoglobin (numeric variable). Estimates in bold are statistically significant ( p < 0.050). Interpretation: in
comparison to being a resident of rural Puno or of a low altitude site, the eGFR is expected to be higher or lower in a magnitude equal to the
b value. Higher degree of urbanization is represented by the number of crosses ({). The regression model for altitude above the sea level
among urban sites excluded Tumbes and rural Puno.
95% CI, 95% confidence interval; BMI, body mass index; eGFR, estimated glomerular filtration rate.
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Puno (high altitude and highly rural). The evidence sug-
gesting that risk factors for impaired kidney function, namely
diabetes and hypertension, are more prevalent in Lima versus
rural Puno does not support this observation. In addition,
contrary to what had been expected, our results also sug-
gested that there could be higher eGFR in Tumbes (sea level)
than urban Puno (high altitude), even though the prevalence
of clinical risk factors for impaired eGFR was higher in
Tumbes. Although largely speculative, we could argue that
living at low altitude could delay, not necessarily prevent,
renal damage in the presence of other relevant clinical risk
factors for low eGFR (e.g., hypertension). Probably, the
protective effect of low altitude could even outweigh the
negative effects of established clinical risk factors. Long-
itudinal studies are needed to assess this hypothesis.
There could be other potential explanation for the similar
eGFR between Lima and rural Puno. Lima was the study site
with the second highest anemia prevalence. Anemia would
trigger erythropoietin production ( Jelkmann, 2011). Because
erythropoietin may have renoprotective properties (Kur-
iyama et al., 1997; Tsubakihara et al., 2012; Covic et al.,
2014), its enhanced production would prevent eGFR from
decreasing. Nevertheless, although Tumbes was the site with
the highest anemia prevalence and thus should have also had
higher eGFR values, we argue that because Tumbes is also
the site with the highest prevalence of other relevant clinical
risk factors (e.g., diabetes and hypertension), the potential
protective effect of erythropoietin was outweighed by the
negative effects of the other risk factors. This last speculation
would also explain the eGFR difference between rural and
urban Puno. Although both are at high altitude hence in a
hypoxemic environment which would increase erythropoie-
tin production ( Jelkmann, 2011), the fact that urban Puno has
higher prevalence of diabetes and hypertension would ex-
plain the lower eGFR in comparison to rural Puno.
Finally, we could also argue that the lack of difference
between Lima and rural Puno was due to confounding. In
fact, we could argue that both Puno sites could have higher
eGFR values. Puno sites had high prevalence of polycythe-
mia hence the postcapillary oncotic pressure would be ex-
pected to be high. When the postcapillary oncotic pressure
becomes similar to the hydrostatic pressure, then a decline in
the glomerular filtration rate would be expected. Conse-
quently, the eGFR in Puno sites could have been higher, so
that rural Puno would have higher eGFR than Lima, perhaps
even showing a strong difference.
Results interpretation: eGFR and altitude
Our results suggest that there is a worse eGFR at high
altitude above the sea level in comparison to low altitude.
When all study sites were included, the effect of altitude on
eGFR was larger at intermediate altitude than at high altitude;
however, when only urban sites were included, there was a
worse eGFR at intermediate and high altitude compared with
low altitude. This suggests that the initial weak estimates at
FIG. 3. Mean (SD) hemoglobin according to eGFR categories and altitude above the sea level. p-Values correspond to the
Bonferroni multiple comparison test (analysis of variance). By column, pairwise relationships where no p-values are shown
were p> 0.050. By row, all pairwise relationships were different at p < 0.001 (only first row showed for simplicity).
Table 2. Association Between Hemoglobin (g/dL) and Estimated Glomerular Filtration Rate
[mL/(min$1.73m2] According to Altitude Above the Sea Level
Overall Low Intermediate High
b (95% CI) b (95% CI) b (95% CI) b (95% CI)
Crude
N = 4125 N= 1806 N = 1599 N= 720
Hemoglobin -0.55 (-0.91 to -0.20) -0.40 (-1.34 to 0.54) 0.75 (0.16 to 1.34) -1.20 (-2.02 to -0.38)
Adjusted
N = 4046 N= 1794 N = 1563 N= 689
Hemoglobin -0.12 (-0.62 to 0.39) -0.19 (-1.29 to 0.91) 0.30 (-0.33 to 0.94) -1.09 (-2.22 to 0.04)
Adjusted models include sex, age (numeric variable), education, hypertension, diabetes, BMI (numeric variable), and height (numeric
variable); the adjusted model for overall also include altitude above the sea level. Estimates in bold are statistically significant ( p< 0.050).
Interpretation: within each altitude category, for one additional hemoglobin unit, the eGFR changes (increases or decreases) in a magnitude
equal to the b value.
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high altitude could have been confused by other features of
urbanization, that is, different epidemiological profiles.
A small study (n = 293) with healthy individuals in La Paz,
Bolivia (3640–4500 m above the sea level) and Lima, Peru,
also concluded that people at high altitude have worse kidney
function (Hurtado-Arestegui et al., 2018); of note, both were
urbanized cities. Our results expand the available evidence
because we included general population, thus accounting for
generalizability of these findings; additionally, we included
intermediate altitude suggesting that the negative association
between altitude and eGFR also exists at around 2000 m
above the sea level.
Results interpretation: hemoglobin and eGFR
at high altitude
The second hypothesis was that higher hemoglobin levels
would be associated with lower eGFR at high altitude only.
Our results partially supported this hypothesis; although the
regression estimates were in the expected direction, the ad-
justed models did not show associations. Nonetheless, in a
subgroup analysis including people with high levels of he-
moglobin, the results did reveal a strong negative association
between hemoglobin and eGFR.
Our results suggest that there is a negative association
between hemoglobin and eGFR at high altitude, particularly
among people with high hemoglobin. Similar findings were
reported by Hurtado-Arestegui et al. (2018) in La Paz and
Lima. Nevertheless, our results suggest that this negative
association seems to be largely of high-altitude places and not
so at intermediate altitude.
Hurtado-Arestegui et al. (2018) argued that worse kidney
function at high altitude could be due to higher hemoglobin
leading to less renal plasma flow (RPF), which in turns in-
creases the kidney filtration fraction trying to keep the fil-
tration rate constant (Lozano and Monge, 1965); this would
eventually cause chronic kidney impairment (Brenner, 1983).
Our results add to those reached by Hurtado-Arestegui et al.
(2018) quantifying the association between hemoglobin and
eGFR across different altitudes levels.
In addition to these mechanisms, the effect of chronic
exposure to hypoxia should not be neglected. A misbalance in
the action of hypoxia-inducible factors may impair kidney
function—tubulointerstitial hypoxia—and lead to end-stage
renal disease (Shoji et al., 2014). Therefore, this mechanism
could also explain our findings.
Implications for clinical practice
Our findings suggest that there could be a negative asso-
ciation between eGFR and hemoglobin at high altitude,
which is likely to be because of a reduced RPF. Therefore,
and according to each clinical scenario, one could try to avoid
other actions that may further compromise the RPF, namely
actions that would lead to a reduced blood flow (e.g., dehy-
dration) or constraint of the afferent arterioles (e.g., use of
nonsteroidal anti-inflammatory drugs). Conversely, it has
been shown that angiotensin-converting enzyme inhibitors
(ACEIs) may reduce hemoglobin level (Leshem-Rubinow
et al., 2012); specifically at high altitude, ACEIs could reduce
polycythemia and proteinuria (Plata et al., 2002). Our results
provided evidence of places where these treatments could be
further tested to benefit large populations.
In our study settings, an external factor that may also play a
relevant role is cold (Broman et al., 1998; Yoon et al., 2014).
Cold weather could increase blood viscosity and also vaso-
constriction. In the last years, extreme cold temperatures
have been experienced in Puno (reliefweb 2015; Vice News).
Current evidence could suggest strengthening prevention
strategies for kidney diseases at high altitude under extreme
cold weather. Our results would suggest strengthening pre-
vention strategies in high-altitude urbanized places.
Finally, it is relevant to pinpoint that these recommenda-
tions should be applied cautiously and specific to the popu-
lation of interest. In other words, these recommendations may
not apply to all individuals living at high altitude because
they may not express the same health consequences. For
example, people living in the Tibet, although exposed to high
altitude, have normal levels of hemoglobin; this is believed to
be due to adaptation over larger periods than the Andes ha-
bitants (Hurtado et al., 2012).
Strengths and limitations
We studied a large sample size living at low, intermedi-
ate, and high altitude above the sea level, in places at dif-
ferent stage of urbanization. Notwithstanding, limitations
should also be acknowledged. In addition to the limitations
of the original data sources (Medina-Lezama et al., 2005;
Miranda et al., 2012), this work has the following pitfalls.
First, we relied on the MDRD equation to assess kidney
function. The accuracy of this equation has not been tested
in our population. However, this would be a nondifferential
misclassification of the outcome variable, leading to a larger
or smaller estimate effect of the regression models. Because
the descriptive results show a consistent pattern with the
regression models, the results provide evidence to support
the conclusions. Second, we did not collect specific details
about the laboratory procedures to analyze blood samples.
Therefore, we cannot definitely rule out that some of the
findings were due to technical issues, that is, differential
misclassification. However, all samples of the CRONICAS
Cohort Study were analyzed by one laboratory, and so were
the samples of the PREVENCION study. If there were
technical issues, these would have been reflected in the re-
sults between these studies but not when comparing sites
within one study (e.g., between Lima and rural Puno, both of
the CRONICAS Cohort Study). Third, due to data avail-
ability, kidney function was based on eGFR alone; there-
fore, our findings could suggest that there is even a larger
population with some level of underlying kidney damage. In
fact, other study in Peru revealed that proteinuria was the
largest contributor to chronic kidney disease prevalence
(Francis et al., 2015). In addition, the high altitude renal
syndrome, which presents preserved kidney function (Are-
stegui et al., 2011), may have also hidden a larger preva-
lence of impaired kidney function. Fourth, variables
addressing diet profiles were not available, so meat con-
sumption, a relevant actor in creatinine metabolism, could
not be adjusted for in the results; access to health care could
have been a potential confounder too, although it was not
available for adjustment. Fifth, BMI does not necessary
represent muscle mass, which is also relevant in creatinine
metabolism. We did not have a comprehensive measure-
ment of muscle mass. However, in post hoc analysis and
only for the CRONICAS Cohort Study because of data
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availability, we tested the fully adjusted regression models
without BMI but including lean mass (kg). The results were
virtually the same to the findings already shown; the only
relevant difference was in the association between hemo-
globin and eGFR at high altitude, which now depicted a
strong negative association (-1.23; 95% CI: -2.24 to
-0.22). This post hoc finding suggests that there is probably
a negative association, but our main results were under-
powered. Sixth, there was not an indicator of time exposed
to each altitude level. This information would be relevant to
further dissect the negative association between hemoglobin
and eGFR at high altitude and to understand the effect of
acute and chronic exposure to high altitude. Nevertheless,
more than 65% of the population in urban Puno, Tumbes,
and rural Puno has always lived in their study site, thus
being chronically exposed to the corresponding altitude
above the sea level. When the mean eGFR across study sites
was estimated for those who reported to have always lived
in the same place, the results presented in Figure 1 did not
change substantially.
Conclusions
It seems that higher altitude and higher level of urbaniza-
tion, except for one highly urbanized site, were associated
with worse kidney function. Our findings suggest that to date,
some of the adverse impact of high altitude on kidney func-
tion has been balanced by the lower risk conferred by rural
environments. However, increased urbanization at high alti-
tude settings is likely to markedly increase the risk of chronic
kidney disease among sizeable populations living at high
altitude worldwide.
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